Ovarian aging: mechanisms and clinical consequences - PubMed

Affiliations

• PMID: 19589949
• DOI: 10.1210/er.2009-0006

Review

Ovarian aging: mechanisms and clinical consequences

F J Broekmans et al. Endocr Rev. 2009 Aug.

Abstract

Menopause is the final step in the process referred to as ovarian ageing. The age related decrease in follicle numbers dictates the onset of cycle irregularity and the final cessation of menses. The parallel decay in oocyte quality contributes to the gradual decline in fertility and the final occurrence of natural sterility. Endocrine changes mainly relate to the decline in the negative feedback from ovarian factors at the hypothalamo-pituitary unit. The declining cohort of antral follicles with age first results in gradually elevated FSH levels, followed by subsequent stages of overt cycle irregularity. The gradual decline in the size of the antral follicle cohort is best represented by decreasing levels of anti-Mullerian hormone. The variability of ovarian ageing among women is evident from the large variation in age at menopause. The identification of women who have severely decreased ovarian reserve for their age is clinically relevant. Ovarian reserve tests have appeared to be fairly accurate in predicting response to ovarian stimulation in the assisted reproductive technology (ART) setting. The capacity to predict the chances for spontaneous pregnancy or pregnancy after ART appears very limited. As menopause and the preceding decline in oocyte quality seem to have a fixed time interval, tests that predict the age at menopause may be useful to assess individual reproductive lifespan. Especially genetic studies, both addressing candidate gene and genome wide association, have identified several interesting loci of small genetic variation that may determine fetal follicle pool development and subsequent wastage of his pool over time. Improved knowledge of the ovarian ageing mechanisms may ultimately provide tools for prediction of menopause and manipulation of the early steps of folliculogenesis for the purpose of contraception and fertility lifespan extension.

Similar articles

• Female reproductive ageing: current knowledge and future trends.

  Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Broekmans FJ, et al. Trends Endocrinol Metab. 2007 Mar;18(2):58-65. doi: 10.1016/j.tem.2007.01.004. Epub 2007 Feb 1. Trends Endocrinol Metab. 2007. PMID: 17275321 Review.

• Reproductive potential in the older woman.

  Gindoff PR, Jewelewicz R. Gindoff PR, et al. Fertil Steril. 1986 Dec;46(6):989-1001. doi: 10.1016/s0015-0282(16)49869-9. Fertil Steril. 1986. PMID: 3536609 Review.

• Ovarian aging and implications for fertility female health.

  Younis JS. Younis JS. Minerva Endocrinol. 2012 Mar;37(1):41-57. Minerva Endocrinol. 2012. PMID: 22382614 Review.

• Testing ovarian reserve to predict age at menopause.

  Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Lambalk CB, et al. Maturitas. 2009 Aug 20;63(4):280-91. doi: 10.1016/j.maturitas.2009.06.007. Epub 2009 Jul 23. Maturitas. 2009. PMID: 19631481 Review.

• Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.

  Klein NA, Battaglia DE, Miller PB, Branigan EF, Giudice LC, Soules MR. Klein NA, et al. J Clin Endocrinol Metab. 1996 May;81(5):1946-51. doi: 10.1210/jcem.81.5.8626862. J Clin Endocrinol Metab. 1996. PMID: 8626862

Cited by

• The Inflammasome Contributes to Depletion of the Ovarian Reserve During Aging in Mice.

  Lliberos C, Liew SH, Mansell A, Hutt KJ. Lliberos C, et al. Front Cell Dev Biol. 2021 Feb 11;8:628473. doi: 10.3389/fcell.2020.628473. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33644037 Free PMC article.

• Stem-Cell-Derived Extracellular Vesicles: Unlocking New Possibilities for Treating Diminished Ovarian Reserve and Premature Ovarian Insufficiency.

  Martirosyan YO, Silachev DN, Nazarenko TA, Birukova AM, Vishnyakova PA, Sukhikh GT. Martirosyan YO, et al. Life (Basel). 2023 Nov 23;13(12):2247. doi: 10.3390/life13122247. Life (Basel). 2023. PMID: 38137848 Free PMC article. Review.

• The Impact of Controlled Ovarian Stimulation Hormones on the Metabolic State and Endocannabinoid System of Human Cumulus Cells.

  Notarstefano V, Gioacchini G, Giorgini E, Montik N, Ciavattini A, Polidori AR, Candela FA, Vaccari L, Cignitti M, Carnevali O. Notarstefano V, et al. Int J Mol Sci. 2020 Sep 27;21(19):7124. doi: 10.3390/ijms21197124. Int J Mol Sci. 2020. PMID: 32992491 Free PMC article.

• Cystathionine β-synthase is required for oocyte quality by ensuring proper meiotic spindle assembly.

  Cao Y, Zhu X, Zhen P, Tian Y, Ji D, Xue K, Yan W, Chai J, Liu H, Wang W. Cao Y, et al. Cell Prolif. 2022 Dec;55(12):e13322. doi: 10.1111/cpr.13322. Epub 2022 Aug 19. Cell Prolif. 2022. PMID: 36053797 Free PMC article.

• Recent advances in understanding primary ovarian insufficiency.

  Wesevich V, Kellen AN, Pal L. Wesevich V, et al. F1000Res. 2020 Sep 7;9:F1000 Faculty Rev-1101. doi: 10.12688/f1000research.26423.1. eCollection 2020. F1000Res. 2020. PMID: 32934798 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program